Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

TABLE 1s. Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending August 28, 2021 (Week 34)
Reporting Area Invasive pneumococcal disease, all ages §
Confirmed Probable
Current weekPrevious 52 weeks Max †Cum YTD 2021 †Cum YTD 2020 †Current weekPrevious 52 weeks Max †Cum YTD 2021 †Cum YTD 2020 †
U.S. Residents, excluding U.S. Territories 77 187 4,557 8,213 3 9 101 132
New England 7 19 185 490 - 1 1 4
Connecticut - 5 47 122 - 0 - 1
Maine 6 10 48 63 - 0 - -
Massachusetts - 5 54 189 - 1 - -
New Hampshire - 3 21 58 - 1 1 2
Rhode Island - 3 12 36 - 0 - -
Vermont 1 1 3 22 - 1 - 1
Middle Atlantic 15 39 545 1,110 1 6 33 39
New Jersey 3 11 84 309 - 3 18 25
New York (excluding New York City) 10 26 209 352 - 2 6 8
New York City 1 14 183 365 1 6 8 1
Pennsylvania 1 6 69 84 - 1 1 5
East North Central 3 38 825 1,537 - 2 16 34
Illinois N NC N N N NC N N
Indiana - 14 198 310 - 1 - 1
Michigan 2 12 160 376 - 1 4 1
Ohio - 19 339 631 - 2 12 32
Wisconsin 1 7 128 220 - 0 - -
West North Central 1 14 215 430 - 2 15 9
Iowa N NC N N N NC N N
Kansas - 0 - - - 0 - -
Minnesota - 1 - 1 - 0 - -
Missouri - 10 125 281 - 2 7 5
Nebraska 1 4 45 80 - 0 - 2
North Dakota - 3 15 34 - 0 - -
South Dakota - 3 30 34 - 2 8 2
South Atlantic 22 40 944 1,382 2 2 10 13
Delaware - 4 35 49 - 0 - -
District of Columbia - 2 11 44 - 0 - -
Florida 16 24 397 450 2 2 7 7
Georgia 6 18 253 359 - 0 - -
Maryland - 8 119 250 - 1 2 -
North Carolina N NC N N N NC N N
South Carolina - 8 39 80 - 1 1 3
Virginia - 2 8 9 - 0 - -
West Virginia - 13 82 141 - 0 - 3
East South Central 9 28 524 868 - 1 4 4
Alabama 1 13 154 203 - 1 1 -
Kentucky - 5 65 179 - 1 3 2
Mississippi 4 7 88 136 - 0 - -
Tennessee 4 15 217 350 - 0 - 2
West South Central 5 55 513 939 - 3 14 17
Arkansas - 10 77 155 - 1 - 1
Louisiana - 13 135 198 - 1 1 3
Oklahoma N NC N N N NC N N
Texas 5 46 301 586 - 3 13 13
Mountain 12 46 705 1,319 - 2 8 5
Arizona 11 38 402 490 - 1 3 1
Colorado - 13 - 272 - 0 - 1
Idaho N NC N N N NC N N
Montana - 4 33 60 - 0 - 2
Nevada 1 8 74 200 - 1 2 -
New Mexico - 7 103 159 - 0 - -
Utah - 9 77 117 - 1 3 1
Wyoming - 2 16 21 - 0 - -
Pacific 3 10 101 138 - 1 - 7
Alaska 3 10 86 108 - 1 - 7
California N NC N N N NC N N
Hawaii - 2 15 30 - 0 - -
Oregon N NC N N N NC N N
Washington N NC N N N NC N N
U.S. Territories - 0 - - - 0 - -
American Samoa N NC N N N NC N N
Commonwealth of Northern Mariana Islands - 0 - - - 0 - -
Guam - 0 - - - 0 - -
Puerto Rico - 0 - - - 0 - -
U.S. Virgin Islands - 0 - - - 0 - -
Non-U.S. Residents - 0 - - - 0 - -
Total 77 187 4,557 8,213 3 9 101 132
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • Max: Maximum — Maximum case count during the previous 52 weeks.
  • * Case counts for reporting years 2020 and 2021 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/docs/Readers-Guide-WONDER-Tables-20210421-508.pdf.
  • †Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Includes drug resistant and susceptible cases of Invasive Pneumococcal Disease.